ROIV — Roivant Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Roivant Sciences, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	2,055	2,060	1,677	6,536	4,887
Net Total Accounts Receivable
Net Total Receivables	13.8	—	32.7	82.8	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,187	2,147	1,799	6,732	5,000
Net Property, Plant And Equipment	77	86.9	92.3	66	101
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	2,590	2,585	2,390	7,222	5,437
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	219	184	272	267	149
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	792	928	1,232	1,254	749
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,798	1,657	1,158	5,969	4,688
Total Liabilities & Shareholders' Equity	2,590	2,585	2,390	7,222	5,437
Total Common Shares Outstanding